Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien-Ching Hung

Showing results (271-280 of 388) with videos related to

Pageof 39
Sort By:
AIDS (London, England)|November 10, 2017
Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapyUn-In Wu, Chien-Ching Hung, Sui-Yuan Chang, et al.
AIDS Research and Human Retroviruses|December 7, 2006
Molecular epidemiology of HIV type 1 subtypes in Taiwan: outbreak of HIV type 1 CRF07_BC infection in intravenous drug usersSui-Yuan Chang, Wang-Huei Sheng, Chun-Nan Lee, et al.
Emerging Infectious Diseases|June 18, 2004
SARS in hospital emergency roomYee-Chun Chen, Li-Min Huang, Chang-Chuan Chan, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 18, 2020
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppressionWei-Chieh Huang, Chun-Kai Huang, Sung-Hsi Huang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 30, 2024
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in treatment-naïve and treatment-experienced people with HIV: Findings from the Asia cohort of the BICSTaR studyYu-Ting Tseng, Chia-Jui Yang, Yeon-Sook Kim, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 22, 2024
Mycoplasma genitalium infection and resistance-associated mutations to macrolides and fluoroquinolones among high-risk patients in TaiwanMing-Jui Tsai, Hsin-Yun Sun, Li-Hsin Su, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIVSung-Hsi Huang, Wei-Chieh Huang, Shu-Wen Lin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2019
Effect of a Hepatitis A Vaccination Campaign During a Hepatitis A Outbreak in Taiwan, 2015-2017: A Modeling StudyKuan-Yin Lin, Hsin-Yun Sun, Yi-Hsuan Chen, et al.
Hepatology International|June 10, 2019
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfectionYu-Shan Huang, Hsin-Yun Sun, Sui-Yuan Chang, et al.
Plos One|September 12, 2015
Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral TherapyKuan-Yin Lin, Sih-Han Liao, Wen-Chun Liu, et al.
Pageof 39

Showing results (271-280 of 388) with videos related to

Sort By:
Pageof 39
AIDS (London, England)|November 10, 2017
Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapyUn-In Wu, Chien-Ching Hung, Sui-Yuan Chang, et al.
AIDS Research and Human Retroviruses|December 7, 2006
Molecular epidemiology of HIV type 1 subtypes in Taiwan: outbreak of HIV type 1 CRF07_BC infection in intravenous drug usersSui-Yuan Chang, Wang-Huei Sheng, Chun-Nan Lee, et al.
Emerging Infectious Diseases|June 18, 2004
SARS in hospital emergency roomYee-Chun Chen, Li-Min Huang, Chang-Chuan Chan, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 18, 2020
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppressionWei-Chieh Huang, Chun-Kai Huang, Sung-Hsi Huang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 30, 2024
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in treatment-naïve and treatment-experienced people with HIV: Findings from the Asia cohort of the BICSTaR studyYu-Ting Tseng, Chia-Jui Yang, Yeon-Sook Kim, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 22, 2024
Mycoplasma genitalium infection and resistance-associated mutations to macrolides and fluoroquinolones among high-risk patients in TaiwanMing-Jui Tsai, Hsin-Yun Sun, Li-Hsin Su, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIVSung-Hsi Huang, Wei-Chieh Huang, Shu-Wen Lin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2019
Effect of a Hepatitis A Vaccination Campaign During a Hepatitis A Outbreak in Taiwan, 2015-2017: A Modeling StudyKuan-Yin Lin, Hsin-Yun Sun, Yi-Hsuan Chen, et al.
Hepatology International|June 10, 2019
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfectionYu-Shan Huang, Hsin-Yun Sun, Sui-Yuan Chang, et al.
Plos One|September 12, 2015
Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral TherapyKuan-Yin Lin, Sih-Han Liao, Wen-Chun Liu, et al.
Pageof 39